These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9844225)

  • 1. [Cost-effectiveness analysis of the eradication of Helicobacter pylori as treatment for duodenal ulcer].
    Fernández Muñoz J; López de Andrés A; Zapater Hernández P; Abad Santos F
    An Med Interna; 1998 Oct; 15(10):515-22. PubMed ID: 9844225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
    O'Brien B; Goeree R; Mohamed AH; Hunt R
    Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
    Ofman J; Wallace J; Badamgarav E; Chiou CF; Henning J; Laine L
    Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
    Fendrick AM; Chernew ME; Hirth RA; Bloom BS
    Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Helicobacter pylori infection in patients with duodenal ulcer: a cost-benefit study].
    Rollán A; Giancaspero R; Acevedo C; Fuster F; Hola K
    Rev Med Chil; 2000 Apr; 128(4):367-77. PubMed ID: 10962853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
    Carrère MO; Auquier P; Poynard T; Sambuc R
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
    Ghoshal UC; Das A
    Natl Med J India; 2002; 15(3):140-4. PubMed ID: 12186326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
    Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
    Schütze K; Hentschel E; Hirschl AM
    Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness of the eradication of Helicobacter pylori in the treatment of duodenal ulcer].
    Domínguez Muñoz JE
    An Med Interna; 1998 Oct; 15(10):513-4. PubMed ID: 9844224
    [No Abstract]   [Full Text] [Related]  

  • 17. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H; Perie F; Joubert-Collin M
    Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
    Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.